Excellent blood sugar control by liraglutide in diabetics on beta-blockers
Written By : Dr. Kamal Kant Kohli
Published On 2020-05-26 06:00 GMT | Update On 2023-10-07 11:06 GMT
Advertisement
The glucagon-like peptide-1 (GLP-1) agonist drug, liraglutide, seems to provide excellent blood sugar control in patients with type 2 diabetes who are also taking a beta-blocker, specifically propranolol, to prevent bleeding from esophageal varices due to cirrhosis, but it seems to hamper the pharmacological effects of beta-blockers.
A case report has been published in Annals of Internal Medicine.
Cirrhosis is the leading cause of portal hypertension with an increased risk of developing esophageal varices.Beta-blockers are used to lower portal pressure and decrease the risk of bleeding from esophageal varices and decrease mortality.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.